207 related articles for article (PubMed ID: 24636401)
21. [Gonadotropin-releasing hormone antagonist protocol in patients with risk of poor response to ovarian stimulation in IVF-ET].
Sun Y; Zhu YM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 May; 38(3):305-10. PubMed ID: 19504641
[TBL] [Abstract][Full Text] [Related]
22. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
[TBL] [Abstract][Full Text] [Related]
23. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
24. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
25. GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.
Olgan S; Humaidan P
Reprod Biol; 2017 Mar; 17(1):105-110. PubMed ID: 28173995
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
27. "Delayed start" gonadotropin-releasing hormone antagonist protocol in Bologna poor-responders: A systematic review and meta-analysis of randomized controlled trials.
Cozzolino M; Franasiak J; Andrisani A; Ambrosini G; Vitagliano A
Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():154-162. PubMed ID: 31786492
[TBL] [Abstract][Full Text] [Related]
28. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
[TBL] [Abstract][Full Text] [Related]
29. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.
Oehninger S; Nelson SM; Verweij P; Stegmann BJ
Reprod Biol Endocrinol; 2015 Oct; 13():117. PubMed ID: 26520396
[TBL] [Abstract][Full Text] [Related]
31. Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial.
Giles J; Alama P; Gamiz P; Vidal C; Badia P; Pellicer A; Bosch E
Fertil Steril; 2021 Aug; 116(2):404-412. PubMed ID: 33814126
[TBL] [Abstract][Full Text] [Related]
32. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
33. Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.
Cavagna M; Maldonado LG; de Souza Bonetti TC; de Almeida Ferreira Braga DP; Iaconelli A; Borges E
Fertil Steril; 2010 Jun; 94(1):167-72. PubMed ID: 19342035
[TBL] [Abstract][Full Text] [Related]
34. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
Mohsen IA; El Din RE
Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
[TBL] [Abstract][Full Text] [Related]
35. ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation.
Bercaire L; Nogueira SM; Lima PC; Alves VR; Donadio N; Dzik A; Cavagna M
JBRA Assist Reprod; 2018 Mar; 22(1):52-55. PubMed ID: 29303236
[TBL] [Abstract][Full Text] [Related]
36. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
37. What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?
Samara N; Reis D; Danielli Miller N; Ghetler Y; Berkovitz A; Miller M; Gonen O; Shulman A; Wiser A
Gynecol Endocrinol; 2015; 31(11):877-9. PubMed ID: 26416777
[TBL] [Abstract][Full Text] [Related]
38. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
39. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
[TBL] [Abstract][Full Text] [Related]
40. Effect of length of controlled ovarian hyperstimulation using a gonadotropin-releasing hormone antagonist on in vitro fertilization pregnancy rates.
Royster GD; Retzloff MG; Robinson RD; King JA; Propst AM
J Reprod Med; 2012; 57(9-10):415-20. PubMed ID: 23091989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]